NeoScreenPak is a single-format test package which will be used to screen for seven of the eleven most commonly screened disorders affecting newborns.
Enzolve’s ‘one-step’ tests are faster and more reliable, convenient and cost effective than tests currently available on the market.
Website supported by
Search
Latest News
Newborn
Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…
Screen
your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…
UCD
campus company to begin production of newborn screening kits
for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…